Dabrafenib Impurities and its Related Products
Displaying
15 results of
Dabrafenib Impurities
Dabrafenib is a drug used to treat melanoma, a type of skin cancer. Impurities in Dabrafenib can affect the drug's efficacy and safety. These impurities may be formed during the manufacturing process or may be introduced during storage and transportation. Therefore, it is important to identify and control these impurities to ensure the quality and safety of Dabrafenib.
CAT No.
: CS-O-45558
Mol F.
: C₆H₄F₂O₃S
Mol W.
:
194.16 g/mol
Cas No.
: 686258-75-3
Stock
: In Stock
CAT No.
: CS-BX-01346
Mol F.
: C6H3ClF2
Mol W.
:
148.54 g/mol
Cas No.
: 38361-37-4
Stock
: Enquire
CAT No.
: CS-BX-01347
Mol F.
: C5H8N2O2
Mol W.
:
128.13 g/mol
Cas No.
: 2434-49-3
Stock
: Enquire
CAT No.
: CS-O-45559
Mol F.
: C13H8F3NO4S
Mol W.
:
331.27 g/mol
Cas No.
: Not Available
Stock
: In Stock
CAT No.
: CS-O-45560
Mol F.
: C18H11ClF3N3O3S
Mol W.
:
441.81 g/mol
Cas No.
: 1195768-20-7
Stock
: In Stock
CAT No.
: CS-EO-03170
Mol F.
: C23H22F2N6O2S2
Mol W.
:
516.6 g/mol
Cas No.
: 2017554-98-0
Stock
: Enquire
CAT No.
: CS-EO-04024
Mol F.
: C6H3F3O2S
Mol W.
:
196.15 g/mol
Cas No.
: 447460-43-7
Stock
: Enquire
CAT No.
: CS-EO-03169
Mol F.
: C24H23F2N5O3S2
Mol W.
:
531.6 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-EO-04023
Mol F.
: C23H21F3N4O4S2
Mol W.
:
538.56 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-EO-03952
Mol F.
: C23H21F2N5O2S2
Mol W.
:
501.57 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-EO-03171
Mol F.
: C9H11NO3
Mol W.
:
181.2 g/mol
Cas No.
: 5129-25-9
Stock
: Enquire
CAT No.
: CS-O-59742
Mol F.
: C24H21F3N4O3S2
Mol W.
:
534.6 g/mol
Cas No.
: 1907654-22-1
Stock
: Enquire
CAT No.
: CS-O-56918
Mol F.
: C23H20F3N5O3S2
Mol W.
:
535.6 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-45561
Mol F.
: C23H20ClF3N4O3S2
Mol W.
:
557.01 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-46555
Mol F.
: C23H18ClF3N4O2S2
Mol W.
:
538.99 g/mol
Cas No.
: 1195768-23-0
Stock
: Enquire
